Skip to main content

Table 2 LV and LA dimensions and extent of late gadolinium enhancement in HCM patients.

From: CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation

 

Atrial fibrillation (n= 37)

No atrial fibrillation (n= 50)

p-value

Age (years)

59 ± 15

56 ± 11

0.40

LV ejection fraction (%)

56 ± 10

61 ± 10

0.07

LV mass (gr·m-2)

97 ± 31

99 ± 34

0.76

LV EDD (mm)

51 ± 7

49 ± 8

0.51

SWT (mm)

19 ± 6

18 ± 4

0.28

PWT (mm)

10 ± 3

11 ± 3

0.28

LVEDV (mL·m-2)

86 ± 23

79 ± 20

0.16

LVESV (mL·m-2)

37 ± 14

31 ± 11

0.07

LVSV (mL·m-2)

49 ± 15

50 ± 15

0.89

LA volume (mL·m-2)

68 ± 24

46 ± 18

0.0002

LGE (%)

12.4 ± 14.5

6.0 ± 8.6

0.02

  1. Data are presented as ± standard deviation. Volumes are indexed to body surface area. EDD = end diastolic dimension, EDV = end diastolic volume, ESV = end systolic volume, LA = left atrial, LGE = late gadolinium enhancement, LV= left ventricular, PWT = posterior wall thickness, SWT = septal wall thickness
Back to article page

Journal of Cardiovascular Magnetic Resonance

ISSN: 1532-429X

Contact us